ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 605099 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 605099; 2) Community: the network communities that were significantly associated with the response to NSC 605099; 3) Molecule: the relationships between components within communities and NSC 605099; 4) MDR: the compounds that were significantly associated with the NSC 605099.

NSC Compound Enrichment Correlation
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.000706163530262832 0.54689408
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.000706163530262832 0.63255277
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.000706163530262832 0.56624084
NSC 624172 Null 0.000706163530262832 0.46335556
NSC 629868 Null 0.000706163530262832 -0.25869448
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.000706163530262832 0.65092776
NSC 639187 Landomycin A 0.000706163530262832 0.64656976
NSC 639981 Null 0.000706163530262832 0.61325134
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.000706163530262832 0.20795899
NSC 663285 6-N-(Aminoethyl-2-(4-morpholino))-6-chloro-5,8-quinolinedione 0.000706163530262832 0.51726123
Total:176  Current:11    [First] [Prev] [Next] [Last]